Characteristics
Database last updated : 11 Oct 2024
Gene Therapy Trials
Biological Sponsor Disorder
AAV2, FIX-WT, AAV-hF.IX, NCT00076557 Avigen¹/CHOP ² Haemophilia B
AAV2, FIX-WT, rAAV-hAAT-F.IX Non-commercial, Avigen/CHOP Haemophilia B
AAV5, FIX-Padua, Hemgenix, NCT03489291 uniQure Haemophilia B
AAV5, FIX-Padua, Hemgenix, NCT03569891 (Phase III, Hope-B Trial) CSL Behring Haemophilia B
AAV5, FIX-WT, AMT-060, uniQure, NCT02396342 uniQure Haemophilia B
AAV5, FVIII-BDD, Roctavian, NCT02576795 (Phase 1/2 Study) BioMarin Pharmaceutical Haemophilia A
AAV5, FVIII-BDD, Roctavian, NCT03370913 (Phase 3, GENEr8-1 Study) BioMarin Pharmaceutical Haemophilia A
AAV5, FVIII-BDD, Roctavian, NCT03370913 and NCT03392974, Data of Participants with HIV BioMarin Pharmaceutical Haemophilia A
AAV6, FIX-WT, SB-FIX, NCT02695160 (No Results Published) Sangamo Therapeutics Haemophilia B
AAV6, FVIII-BDD, Giroctocogene Fitelparvovec (SB-525), NCT03061201 (Phase 1/2) Pfizer/Sangamo Haemophilia A
AAV6, FVIII-BDD, Giroctocogene Fitelparvovec (SB-525), NCT04370054 (Phase 3 study) Pfizer/Sangamo Haemophilia A
AAV8, FIX-Padua, BAX 335, NCT01687608 Baxalta now part of Shire Haemophilia B
AAV8, FIX-WT, scAAV2/8-LP1-hFIXco, NCT00979238 Non-commercial Haemophilia B
AAV8, FVIII-BDD, SHP654 (BAX 888), NCT03370172 Shire Haemophilia A
AAV8, FVIII-V3, AAV2/8-HLP-FVIII-V3, NCT03001830 University College, London Haemophilia A
AAVhu37, FVIII-BDD, DTX201, NCT03588299 Bayer/Ultragenyx Haemophilia A
AAVrh10, FIX-WT, DTX101, NCT02618915 Dimension Therapeutics Haemophilia B
AAVS3, FIX-Padua, FLT180a, NCT03369444 University College, London Haemophilia B
AAV-Spark100, FIX-Padua, Fidanacogene elaparvovec (ᴾʳBEQVEZ™), NCT02484092 Pfizer Haemophilia B
AAV-Spark100, FIX-Padua, Fidanacogene elaparvovec (ᴾʳBEQVEZ™), NCT03861273 (Phase 3, BeneGene-2) Pfizer Haemophilia B
AAV-SPK200, FVIII-BDD, Dirloctocogene samoparvovec (SPK-8011), NCT03003533 and NCT03432520 Roche/Spark Therapeutics Haemophilia A
Bioengineered AAV capsid, FVIII-BDD, SPK-8016, NCT03734588 and NCT03432520 Spark Therapeutics Haemophilia A
LV, FVIII, YUVA-GT-F801, NCT03217032 (no results published) Shenzhen Geno-Immune Medical Institute Haemophilia A
LV, FVIII-ET3, CD68-ET3-LV CD34+, Expression Therapeutics, NCT04418414 (no results published) Expression Therapeutics, LLC Haemophilia A